If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIdox Group Regulatory News (IDOX)

Share Price Information for Idox Group (IDOX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.00
Bid: 64.20
Ask: 65.80
Change: 0.60 (0.93%)
Spread: 1.60 (2.492%)
Open: 64.00
High: 65.00
Low: 64.00
Prev. Close: 64.40
IDOX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Statement

16 Nov 2022 07:00

RNS Number : 5282G
IDOX PLC
16 November 2022
 

16 November 2022

Idox plc

('Idox', the 'Group' or the 'Company')

Year End Trading Update

A resilient performance

 

Idox plc (AIM: IDOX), a leading supplier of specialist information management software and solutions to the public and asset intensive sectors, today issues a trading update for its financial year ended 31 October 2022 ('FY22').

 

 

Group trading performance

 

We are pleased to report Idox has delivered a resilient performance for FY22 against a backdrop of economic uncertainty. We have continued to make progress towards a number of our medium-term strategic goals, putting the Group on a strong footing for the future.

 

Our focus on winning and retaining long-term recurring revenue contracts with high quality customers has resulted in record full year order intake in excess of c. £74m, up 19% on FY21, providing good visibility into FY23.

 

The Board expects to report (subject to audit) a c. 15% increase in full year adjusted EBITDA to c. £22.5m, in line with management's expectations. Revenue is expected to be up 6% to c. £66m, and recurring revenue is anticipated to be up c. 12% over the period to c. £40.5m. As a result, the Group expects to deliver an improved adjusted EBITDA margin of c. 34% (FY21: 31%).

 

The Group's net debt at year-end was £6.7m, a reduction since 31 October 2021 (£8.1m net debt). The Group continues to maintain significant balance sheet flexibility and strength, including a £35m revolving credit facility and a £10m accordion.

 

As reported in early October, Idox acquired Landhawk, a land mapping and GIS data business, for £1.5m, including an initial cash consideration of £1.1m. Landhawk further strengthens the Group's GIS capabilities following the acquisitions of Aligned Assets, thinkWhere and exeGesIS in FY21. We continue to pursue a number of acquisition opportunities but remain focussed on ensuring strategic alignment whilst maintaining a disciplined approach to valuations.

 

We have started FY23 with strong recurring revenue and good levels of contract renewals, a solid order book and a healthy pipeline. As a result, our expectations for FY23 remain unchanged, albeit we remain cognisant of the current economic environment.

 

 

David Meaden, Chief Executive Officer of Idox commented:

 

"We have laid the foundations for sustained success at Idox, and against a challenging macro-economic backdrop, we have delivered a robust set of results.

With recurring revenue and order intake up, we are well positioned to continue our success over the coming years, supported by a strong balance sheet.

 

Pleasingly, we have seen significant success in areas of strategic focus, notably with Idox Cloud where we have seen 15 new sales during the period, which bodes well for our future performance.

 The integration of recent acquisitions into the Group has progressed well and we have made several adjustments to our operating business, building capacity for future growth. I am pleased that our leadership development programme has ensured that all new senior appointees have been internal candidates.

 

We have a strong balance sheet position, leaving us well placed for an accretive buy and build programme. This, alongside our accelerating organic growth, will create significant value for shareholders and wider stakeholders going forward."

 

 

 

 

 

 

Notice of results

 

The Group expects to report its FY22 results in late January 2023. Management intends to host a results webinar on the day. Please contact MHP Communications to register your interest.

 

 

Definitions

 

Adjusted EBITDA is defined as earnings before amortisation, depreciation, restructuring, acquisition costs, impairment, financing costs and share option costs.

 

Net debt is defined as the aggregation of cash, bank borrowings and long-term bond.

 

 

For further information please contact:

 

Idox plc

Chris Stone, Non-Executive Chairman

David Meaden, Chief Executive Officer

Anoop Kang, Chief Financial Officer

 

+44 (0) 870 333 7101

investorrelations@idoxgroup.com

Peel Hunt LLP (NOMAD and Broker)

Paul Gillam

Michael Burke

James Smith

 

+44 (0) 20 7418 8900

MHP Communications

Reg Hoare

Ollie Hoare

Matthew Taylor

 

+ 44 (0) 20 3128 8276

idox@mhpc.com

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFELLFLFLLFBK
Date   Source Headline
16th Mar 20207:00 amRNSTrading Update and Notice of Results update
7th Feb 202011:33 amRNSHolding(s) in Company
7th Feb 202011:29 amRNSNotice of Results
23rd Jan 20207:00 amRNSChange of Adviser and Notice of Results
22nd Jan 202012:44 pmRNSAIM Rule 17 Schedule Two (g) Update
17th Jan 202012:12 pmRNSDirectors' Dealings & Holdings in Company
3rd Jan 20207:00 amRNSDirectors' Dealings & Holdings in Company
24th Dec 201912:49 pmRNSDirectors' Dealings & Holdings in Company
19th Dec 20197:00 amRNSNew Banking Facilities
2nd Dec 20192:45 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:54 pmRNSDirectors' Dealings & Holdings in Company
27th Nov 20192:10 pmRNSHolding(s) in Company
27th Nov 20192:08 pmRNSHolding(s) in Company
25th Nov 20197:00 amRNSYear End Trading Update
3rd Oct 20192:09 pmRNSExercise of Share Options & Total Voting Rights
17th Sep 20193:03 pmRNSHolding(s) in Company
30th Aug 201910:02 amRNSHolding(s) in Company
30th Aug 20198:18 amRNSHolding(s) in Company
30th Aug 20198:16 amRNSHolding(s) in Company
30th Aug 20197:00 amRNSDirectors' Dealings & Holdings in Company
20th Aug 20199:20 amRNSHolding(s) in Company
9th Aug 20193:16 pmRNSCompletion of Acquisition of Tascomi Ltd
8th Aug 201910:56 amRNSHolding(s) in Company
6th Aug 20198:06 amRNSDirectors' Dealings & Holdings in Company
31st Jul 201910:30 amRNSFurther Details on the Fundraising
31st Jul 20197:00 amRNSProposed Fundraising via accelerated bookbuild
22nd Jul 20197:00 amRNSHalf-year Report
4th Apr 20194:17 pmRNSDirector/PDMR Share Dealing
3rd Apr 20197:00 amRNSBoard Change
29th Mar 20191:08 pmRNSResult of AGM
29th Mar 20197:00 amRNSAGM Trading Update & 2016 Prior Year Adjustment
22nd Mar 20197:00 amRNSDirectorate Change
18th Mar 20195:16 pmRNSOption Awards
12th Mar 20193:17 pmRNSDirector Dealings and Option Awards
7th Mar 20191:29 pmRNSPosting of Annual Report and Notice of AGM
21st Feb 20197:00 amRNSFinal Results for the year ended 31 October 2018
20th Feb 20192:13 pmRNSExercise of Share Options & Total Voting Rights
1st Feb 20198:20 amRNSHolding(s) in Company
29th Jan 20197:00 amRNSExtension of Banking Facilities
22nd Jan 20198:24 amRNSHolding(s) in Company
7th Jan 20192:50 pmRNSBoard Change
27th Nov 20187:00 amRNSYear End Trading Update
22nd Nov 20187:00 amRNSDirectorate Change
19th Nov 20187:00 amRNSDirectorate Change
5th Nov 20187:00 amRNSDisposal of Digital division
31st Oct 20187:00 amRNSDirectorate Change
25th Oct 20183:23 pmRNSHolding(s) in Company
19th Oct 20185:01 pmRNSHolding(s) in Company
15th Oct 20187:00 amRNSAppointment of Chief Financial Officer
12th Sep 20183:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.